
    
      This study is a multi-institutional, non-randomized pilot study that aims to assess the
      safety and toxicity of hepatic arterial radioembolization using SIR-Spheres yttrium-90
      microspheres (SIR-Spheres microspheres) in the treatment of patients with unresectable
      primary hepatocellular carcinoma (HCC). The study aims to recruit 40 patients over a period
      of 24 months.
    
  